Renewal PA requests for members who have CRSwNP must include supporting clinical information and copies of the member's current medical records demonstrating that the member had a significant reduction in CRSwNP symptoms compared to the member's baseline prior to the initiation of Nucala
Comparative Analysis: Three Approaches to Sexual Health Different Tools for Different Challenges PT-141 is best suited for: Hypoactive sexual desire disorder When desire is the primary issue Premenopausal women (approved indication) Off-label investigation: men with desire-related ED, combination with PDE5 inhibitors Melanotan II is NOT recommended due to: Lack of regulatory approval anywhere in the world Uncontrolled quality from gray-market sources Non-selective effects (cannot separate tanning from sexual effects) Potential melanoma concerns Regulatory warnings from multiple health authorities Kisspeptin is best suited for: Fertility treatment (IVF triggering) Hypothalamic dysfunction Research into reproductive axis function Potentially sexual desire (emerging data) Safety Considerations Comparative Safety Profiles Quality and Source Concerns For non-approved compounds such as Melanotan II and research-grade kisspeptin, products from unregulated sources carry contamination risk, purity cannot be verified, dosing accuracy is uncertain, and no manufacturing oversight exists
Enhance athletic performance*
JAMA 315 , 9901004 (2016)
Hepatology consultation before starting weight loss medication is the standard of care for anyone with documented liver cirrhosis
DV: 5.2 mm, and for CA1 at AP: 3.24 mm
